Objective:To investigate the protective effect of FK866 on acute liver injury(ALI) induced by acetaminophen(APAP) and its mechanism. Methods:Twenty-four male C57BL/6 mice(6-week-old) were randomly divided into the control group,FK866 group,APAP group and FK866+APAP group. The activities of alanine aminotransferase(ALT) and aspartate aminotransferase(AST) in serum were determined by colorimetric method,the pathological changes of liver by HE(hematoxylin eosin) staining,the levels of tu-mor necrosis factor-α(TNF-α),interleukin-6(IL-6) and interleukin-1β(IL-1β) by ELISA,and the expression of nicotinamide phosphoribosyltransferase(NAMPT) by Western blot. Results:In the FK866+APAP group,the serum activities of ALT and AST were (13.969±0.290) and (7.150±0.669) IU/L respectively and significantly lower than those of the APAP group(ALT:F=364.709,P=0.000;AST:F=130.398,P=0.000). The lobular structure was clear,the cell degeneration was mild,and no obvious congestion was observed in FK866-treated group. Furthermore,the serum levels of IL-6,IL-1β and TNF-α were (176.333±0.775),(79.765±1.000) and (147.083±1.000) pg/mL respectively,indicating the inflammatory factors were notably inhibited by FK866(F=207.106,P=0.000;F=165.027,P=0.000;F=118.636,P=0.000). The expression of NAMPT protein was also down-regulated. Conclusion:FK866 can protect against the acute liver injury induced by APAP,and the anti-inflammatory effects may be involved in it.